Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02726945 · ClinicalTrials.gov registry record · NA
Adipose-derived SVF for the Treatment of Knee OA
A NA study, sponsored by GID BIO.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02726945 is a NA study that has completed, run by GID BIO. The registered enrollment target is 39 participants.
The verdict
NCT02726945, a NA study, has completed, sponsored by GID BIO.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This is a pivotal study. The study will examine the safety and efficacy of autologous adipose-derived stromal vascular fraction (SVF) cells processed with the GID SVF-2 device for pain, function and stiffness in the knees of osteoarthritic subjects.
Interventions
- OTHER Placebo
- DEVICE GID SVF-2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02726945
The ClinicalTrials.gov registry entry for NCT02726945 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GID BIO, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02726945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02726945 about?
NCT02726945 is a clinical study titled "Adipose-derived SVF for the Treatment of Knee OA". This is a pivotal study. The study will examine the safety and efficacy of autologous adipose-derived stromal vascular fraction (SVF) cells processed with the GID SVF-2 device for pain, function and stiffness in the knees of osteoarthritic subjects.
What is the current status of trial NCT02726945?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2016-04. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT02726945?
The interventions under investigation include: Placebo (OTHER), GID SVF-2 (DEVICE).
Who is sponsoring clinical trial NCT02726945?
This trial is sponsored by GID BIO, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.